Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole (rRE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02986685 |
|
Recruitment Status : Unknown
Verified November 2016 by Yongquan Shi, Xijing Hospital of Digestive Diseases.
Recruitment status was: Recruiting
First Posted : December 8, 2016
Last Update Posted : December 8, 2016
|
Sponsor:
Xijing Hospital of Digestive Diseases
Collaborators:
Ankang City Central Hospital
Shaanxi Provincial People's Hospital
Baoji Central Hospital
Hanzhong Central Hospital
Information provided by (Responsible Party):
Yongquan Shi, Xijing Hospital of Digestive Diseases
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | October 2017 |
| Estimated Study Completion Date : | November 2017 |